Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.
about
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's diseaseCholinesterase inhibitors for Parkinson's disease dementiaCholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's diseaseCharacterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectorsNucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's diseaseCholinesterase inhibition in Parkinson's diseaseThe influences of age on olfaction: a review.New MRI Biomarkers Advance the Characterization of Parkinson Disease.The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistryA pathological study of the association between Lewy body disease and Alzheimer's disease.The nucleus basalis of Meynert in 20 definite cases of Creutzfeldt-Jakob diseaseCortical Lewy body dementia: clinical features and classification.Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromesAn update on brain imaging in parkinsonian dementiaCell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.Anticholinesterase effect on motor kinematic measures and brain activation in Parkinson's disease.Psychosis in Parkinson's disease.The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expressionTreatment of behavioural symptoms and dementia in Parkinson's disease.Olfaction in Parkinson's disease and related disorders.Toxic effects of human and rodent variants of alpha-synuclein in vivo.Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice.Recognition and management of neuropsychiatric complications in Parkinson's disease.Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.The cholinergic system and Parkinson disease.Cholinergic dysfunction in Parkinson's disease.The interplay of cholinergic function, attention, and falls in Parkinson's disease.Neuronal vulnerability, pathogenesis, and Parkinson's diseaseThe pathology roadmap in Parkinson disease.Mild cognitive impairment in Parkinson's disease.Neuronal vulnerability, pathogenesis, and Parkinson's disease.Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson's disease patients with visual hallucinations.Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline.The nucleus basalis of Meynert in neurological dementing disease: a review.Neurodegenerative disorders and aging. Alzheimer's disease and Parkinson's disease--common ground.
P2860
Q24201307-36FBA989-A18E-45A7-99CC-9148EFB88DE8Q24244668-E6E86B54-AB32-40C9-A2B0-81D49F4CAC66Q24245967-FCAE4AE9-83EE-4CBB-AF29-230B35932049Q27318127-FD7E7A1E-3AB0-4791-8A21-74EF5DE0A384Q28085513-87ED0E3A-DF67-49B1-8290-50C12C52584BQ28870519-F39158EC-0D17-46AB-B1F3-D45DF756817CQ30442659-D6361A7A-B943-4245-8DCC-3DCD80A8C8FCQ30835312-579E94E6-473F-45BE-A235-2D412239367EQ31145409-FD455787-B780-4344-9259-C17893AA45ADQ33627585-2A23BD9C-D6FD-4110-8E28-6EA264998794Q33628428-FD03BAD0-6DC3-44B3-9E7D-772C72A7DDD6Q33629363-C1A7216A-0288-4446-A114-D03A9F4EA31DQ33629696-E874A5EA-92EA-4A71-8F2C-203D176FD438Q33853330-50292911-587D-49E4-8CBF-AD58D33F34A1Q34327937-0209285A-D51A-4908-A1CD-B80F70E66A36Q35024248-BD93A826-FA49-495E-9401-9E78C0ED068EQ35687749-90CA0991-4239-4E85-AA2E-B49E73564E5CQ35863404-74D56D48-E552-4BD2-B221-874ECA1BDD56Q36012226-0BBB0131-9F25-4261-935C-BC39DA89E971Q36089350-FC9F1A1C-7469-4367-9BF0-BA152398B822Q36193915-146BC1BD-1CDE-4BB8-96BF-70AF2EA1A0ABQ36205306-A07B7271-F129-4968-AA4F-8B8014918B88Q36318598-C44784CA-5B4C-499C-9FAE-01FD6E6B0902Q36486037-DFEC7190-1A76-4590-B0E7-E9634FFDA05EQ36673715-A905DF3A-D1C5-4B37-B803-287BF8402D0DQ36724965-DB6536E2-632A-4E7F-A6F0-6B8D6FCC9174Q37671065-C311B49E-67E7-4DFD-AB95-CA56BCD11A2DQ37709932-5ACC99A4-8E13-47F6-A70B-4E43384B44CBQ37928585-37041427-ADDF-4C1E-986E-49BFD307B28CQ38026023-CD60888A-8144-4491-99AB-C7EF2D47263DQ38074519-CB33E74A-C94C-4D4C-94B8-484762E5EAD0Q38090986-7D50F965-6159-4441-B6F7-0F9A30C77178Q38099288-4E7F6EE6-98CF-4642-8E78-D0F55B720509Q38209988-954F6F91-A231-4613-9272-502202900AF1Q38598375-ABF71DAE-6795-46BE-83C0-7A4D96C75773Q38634752-18FB7A1F-E2A4-4A00-8E1A-3D81AACCD826Q38643289-66A90318-46B4-485B-B14B-6DEC9CC42639Q38961546-5DC9E204-2F24-4A48-8EDF-7464B67DBBF4Q39483754-4EB38B6A-73A3-40AB-BBE0-DE97EF3718B7Q39639357-726E8A81-A814-47D5-9E4D-B55D861FB64F
P2860
Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Parkinson's disease: neuron lo ...... ncomitant Alzheimer's disease.
@en
Parkinson's disease: neuron lo ...... ncomitant Alzheimer's disease.
@nl
type
label
Parkinson's disease: neuron lo ...... ncomitant Alzheimer's disease.
@en
Parkinson's disease: neuron lo ...... ncomitant Alzheimer's disease.
@nl
prefLabel
Parkinson's disease: neuron lo ...... ncomitant Alzheimer's disease.
@en
Parkinson's disease: neuron lo ...... ncomitant Alzheimer's disease.
@nl
P2860
P356
P1433
P1476
Parkinson's disease: neuron lo ...... ncomitant Alzheimer's disease.
@en
P2093
P2860
P304
P356
10.1002/ANA.410150503
P577
1984-05-01T00:00:00Z